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Summary 
One of the key sources of information on alcohol and other drug treatment services is the 
Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS NMDS). 
Publicly funded alcohol and other drug treatment services provide information on treatment 
episodes for the AODTS NMDS and the National Drug Strategy 2010–2015 auspices this data 
collection. The collection began in 2000 and these data have been used to inform state, 
territory and Australian government policies, a broad range of research activities and 
treatment service provision.  
State, territory and Australian government stakeholders have approved enhancements to the 
collection, so from 2014 we will provide valuable information for higher quality and more 
targeted treatment services by: 
• counting the number of people accessing alcohol and other drug treatment services in 
Australia  
• exploring patterns of drug treatment people receive  
• analysing pathways of clients through treatment. 
Counting clients 
In 2012–13, a statistical linkage key was introduced into the AODTS NMDS. This linkage key 
enables the number of clients receiving treatment to be counted while continuing to ensure 
the privacy of these individuals receiving treatment. Due to anticipated levels of data quality 
and completeness, the number of clients will be initially estimated using a simple 
deterministic method. The possibility of including extra data items in the collection will be 
explored which may lead to a more sophisticated method being adopted in the future. 
New analyses 
With the introduction of the statistical linkage key, a number of client-based analyses will be 
possible including: 
• estimating the number and rate of clients receiving treatment and the remoteness and 
socioeconomic distribution of the client in the 2012–13 and 2013–14 annual reports 
(available mid-2014 and mid-2015, respectively) 
• more complex analyses on patterns of drug use and pathways through treatment, as data 
with unique client counts accumulate over time 
• longitudinal analysis to give valuable information on the characteristics of different 
client groups, for example, those who return to treatment over many years with multiple 
drugs of concern or treatment types. 
Data development 
Some analyses described in this report either require, or would be improved by, future data 
development activities for this collection. These activities will be considered in the context of 
other possible improvements to data collection to support service planning, policy and 
evidence priorities as well as available resourcing. 

  Developing client-based analyses for reporting on alcohol and other drug treatment services 1 
 1 Introduction 
The Australian National Drug Strategy 2010–2015 is a cooperative plan between Australian, 
state and territory governments and the non-government sector. It has an overarching 
approach of harm minimisation and encompasses 3 pillars: demand reduction, supply 
reduction and harm reduction. Under this strategy, enhancing the availability and use of 
data to inform the delivery and evaluation of services and policy is one of the priorities for 
2010–2015 (MCDS 2011). 
One of the key sources of information on alcohol and other drug treatment services is the 
Alcohol and Other Drug Treatment Services National Minimum Data Set (AODTS NMDS). 
Publicly funded alcohol and other drug treatment services supply information on treatment 
episodes for this collection. However, as the collection does not currently contain unique 
client identifiers, reporting on the data set has been limited to counting closed episodes, 
rather than distinct clients. As clients can have multiple treatment episodes in a financial 
year, the number of episodes does not necessarily equate to the number of clients  
(see AIHW 2013 for further details).  
In 2009, the then Australian Government Department of Health and Ageing funded the 
AIHW to explore the feasibility of introducing a statistical linkage key to enable clients to be 
counted in the AODTS NMDS. The findings of this project were that it was feasible to 
implement a statistical linkage key (AIHW 2009), and in 2011, the relevant bodies, including 
the AODTS NMDS Working Group and National Health Information Standards and 
Statistics Committee, endorsed the implementation of the Statistical Linkage Key 581  
(SLK-581) in the 2012–13 AODTS NMDS.  
The purpose of this report is to present options that the AIHW has considered for generating 
distinct client counts using the SLK-581 and reporting based on distinct numbers of clients. A 
number of approaches are possible, dependent on the quality and completeness of data that 
the AIHW received. The report highlights these planned approaches and summarises them 
in Chapter 2.  
The AIHW will consider such reporting approaches in consultation with the Australian 
Government Department of Health and the AODTS NMDS Working Group during drafting 
of the 2012‒13 AODTS NMDS report (and in future years), in light of the level of 
completeness of SLK data and other data-quality issues. Data development options will also 
be considered in the future as opportunities arise. 
The AIHW welcomes public and stakeholder feedback on the approaches outlined in this 
report. If you would like to provide feedback, please email the AIHW at <aod@aihw.gov.au> 
by Friday 28 February 2014. 
This report contains 5 chapters: 
• Chapter 1 (this chapter) provides an introduction. 
• Chapter 2 gives a list of findings about the generation of linkage keys and the potential 
analyses based on these identifiers. 
• Chapter 3 identifies a method for generating distinct client counts. 
• Chapter 4 explores possible client-based analyses. 
• Chapter 5 examines the inclusion of the client-based analyses in annual reports and 
special topic bulletins.  
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2 Summary of findings 
The AIHW has made a number of findings about its intended approach to work relating to 
statistical methods to count distinct clients in the analysis planned for the 2012–13,  
2013–14 and future reports. The AIHW also presents options for possible future data 
development and analysis for consideration, together with the AODTS NMDS Working 
Group. These are summarised in Table 2.1 below.  
Table 2.1: List of findings for client-based analyses using data on alcohol and other drug treatment 
services 
No. Type Finding 
1 Method selected For analysis of 2012–13 AODTS NMDS data, the AIHW will use simple deterministic linkage.  
2 Method selected The AIHW will conduct analysis of future AODTS NMDS collections using a unique identifier at 
the agency level (resource and data quality dependent). 
3 Data development option The AODTS NMDS Working Group will explore the feasibility of introducing an identifier at the 
state or territory level that is unique to the client in the AODTS NMDS to allow for the use of 
key-based linkage to count distinct clients. 
4 Planned for 2012–13 data The AIHW will analyse the number of clients during the year with treatment episodes that were 
closed in the financial year. 
5 Planned for 2012–13 data The AIHW will analyse existing data (pre-2012–13) to check the proportion of episodes that 
were active in a particular financial year that are also closed in that year. 
6 Planned for 2013–14 data The AIHW will use information on the proportion of episodes that were active in a particular 
year and also closed in that year (Finding 5) to inform the value of including analysis of the 
number of clients on an average day in annual reports. 
7 Data development option The AODTS NMDS Working Group will explore the feasibility of expanding the AODTS NMDS 
to capture all active episodes in a financial year, not just episodes closed in a financial year. 
8 Planned for 2012–13 data The AIHW will analyse the rate of clients during the year with treatment episodes that were 
closed in the financial year. 
9 Planned for 2013–14 data The AIHW will use information on the proportion of episodes that were active in a particular 
year, and also closed in that year, to inform analysis of the rate of clients on an average day. 
10 Planned for 2013–14 data The AIHW will analyse the average number of closed episodes per client.  
11 Planned for 2013–14 data The AIHW will analyse the average length of time clients spent in closed treatment episodes. 
12 Planned for 2013–14 data The AIHW will analyse the remoteness of the client’s usual residence (number and rate). 
13 Data development option The AODTS NMDS Working Group will consider the feasibility of including in the AODTS 
NMDS the Statistical Area of the client’s usual residence at the start of the treatment episode. 
14 Planned for 2013–14 data The AIHW will analyse the socioeconomic status of the client’s usual residence. 
15 Future reports option The AODTS NMDS Working Group may explore the policy relevance of analyses of patterns of 
drug use. 
16 Future reports option The AODTS NMDS Working Group may explore the policy relevance of analyses of 
combinations of patterns of treatment. 
17 Future reports option The AIHW may explore the analysis of pathways through treatment in a thematic bulletin. 
18 Future reports option When enough data are available, the AIHW may include the analysis of pathways through 
treatment in its annual reports. 
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3 Counting the number of clients 
The main unit of measurement in the AODTS NMDS is the closed (completed) treatment 
episode (Box 1). As a unit of measurement, the closed treatment episode cannot provide 
information on the number of clients who access publicly funded alcohol and other drug 
treatment, nor can it give information on the extent of concurrent, sequential or recurrent 
service usage. This is because it is possible for a single individual to receive multiple 
treatment episodes during the reporting period or to access more than one service at a time, 
for different treatments and for different substance use problems. Data on the number of 
clients receiving treatment can be considered as well as data on the population of drug users 
and the population at large to investigate issues such as alcohol and other drug treatment 
coverage and gaps. 
 
Box 1: Defining closed treatment episodes 
The AODTS NMDS has used the closed treatment episode concept as it best reflects clinical 
practice within the AOD sector and captures quality information on service use. A closed 
treatment episode may be for a specific treatment that forms part of a longer term treatment 
plan, for example withdrawal management (detoxification) or it may not, for example 
information and education only. 
Data reported for each treatment episode includes the commencement date, principal drug 
of concern, treatment type and cessation date. A new treatment episode begins when a 
different principal drug of concern is identified, a new treatment type begins, the treatment 
setting changes or an individual has had no contact with the treatment agency for 3 months 
(unless planned). It is therefore possible for an individual to have more than one episode 
over a number of years and/or concurrent treatment episodes within one collection year for 
different substances, or different treatment types or in different settings. For example, a 
person may be seeking withdrawal management for alcohol use, and also receiving 
counselling for benzodiazepine use. These may be 2 separate treatment episodes and will 
appear as separate records in the collection. Further, an individual may access a service (or 
several) more than once in a collection period and each of these episodes will be reported. 
Because of these counting rules, it is not possible to estimate the number of people who 
access AOD treatment within a reporting period or the pattern of service usage. This 
limitation also prevents research into how different treatment types fit together to form a 
treatment plan or pathway. 
 
3.1 Statistical linkage 
To provide information on the patterns of service usage by groups of individuals, it is 
essential to be able to recognise where the same individual is receiving services in different 
places and at different times. This is particularly the case where those services are recorded 
in different information systems which are not linked to each other. To protect individual 
privacy, the individual’s names or other directly identifying information is not usually 
provided for statistical analysis. One method to recognise where the same person is receiving 
multiple services is by using a statistical linkage key. Statistical linkage gives the ability to 
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link records with a high degree of certainty without needing an individual’s identity  
(AIHW 2009). For example, by linking records, we can measure the average number of 
assessments provided to groups of clients with a distinct profile before they move on to 
another treatment. This information is pivotal to plan service delivery and gain a better 
understanding of the health issues which this population faces. 
3.2 Statistical linkage keys 
A statistical linkage key (SLK) is a combination of items that contains enough information to 
link records for statistical analysis, but does not contain enough information to  
re-identify individuals. An SLK can be used within a data collection to count the number of 
clients (the purpose explored in this report), or it can be used between data sets to link 
records relating to the same person.  
SLKs are typically used where a nationally unique client identifier or where full name and 
demographic data are not available. This may be because these data are not collected or 
because they are not provided to the agency undertaking statistical analysis due to privacy 
considerations. In the AODTS NMDS, nationally unique client identifiers are not available 
and an SLK was introduced to maintain client privacy. 
The SLK implemented in the AODTS NMDS is known as the Statistical Linkage Key 581 
(SLK-581), so-named because it contains: 
• 5 letters of a person’s name—second, third and fifth letters of family name and second 
and third letters of given name 
• 8 digits of date of birth—ddmmyyyy 
• 1 digit for sex (1 = male, 2 = female). 
For example, Mary Brown, born on 1 July 1958, would have an SLK-581 of 
RONAR010719582.  
The SLK-581 is used in a number of community services data collections, including the 
Specialist Homelessness Services Collection, the Disability Services NMDS, the Juvenile 
Justice NMDS and the Child Protection NMDS. 
The AODTS NMDS also contains a date accuracy indicator, which was implemented with 
the SLK-581. This indicates the extent to which the date of birth (day, month and year) is 
accurate, estimated or unknown and can be used to improve the use of the SLK-581.  
There are several ways to use SLKs to link records that belong to the same person. These 
methods range from those that need few resources but may result in links being missed, to 
more complex methods that can discover nearly all links but require vast resources. The 
choice of method often depends on the availability of more data beyond the SLK-581. 
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3.3 Methods of linking records belonging to the 
same client 
Simple deterministic method 
The simple deterministic method used to link records is based on exact agreement or 
matching of the linkage variables such as a linkage key. Simple (one-step) deterministic 
record linkage cannot allow for variation in reporting. An example is linking 2 data sets 
based solely on the exact agreement of the SLK-581 only (AIHW 2011).  
The simple deterministic method needs the fewest resources and relies on the assumption 
that distinct SLKs relate to distinct people. A simple deterministic method will have a high 
rate of success where: 
• the key used is adequately distinctive, which means that it has a low rate of false 
positives (where records that actually belong to different people are incorrectly found to 
belong to the same person) and a high rate of true negatives (where records that actually 
belong to different people are correctly shown to belong to different people) 
• the population reports components of the SLK in a consistent manner and these are 
accurately recorded, which means it has a high rate of true positives (where records that 
actually belong to the same person are correctly found to belong to the same person) and 
a low rate of false negatives (where records that actually belong to the same person are 
incorrectly shown to belong to different people). 
Previous work has shown that the SLK-581 is adequately distinctive—in most circumstances, 
relatively few people will share the same SLK-581 combination (AIHW: Ryan et al. 1999). 
However, the components used in the SLK-581 mean that false positives and negatives can 
be introduced both where clerical errors are made (such as where a date of birth is recorded 
incorrectly) and in populations where people are likely to change their name or use aliases. 
For example, if Mary Smith born 1 July 1958 changes her last name to Brown, the values for 
the last name component of the SLK-581 will change, with the result that her SLK-581 
combinations will change from RONAR010719582 to MIHAR010719582. For this client, the 
deterministic method would result in a false negative, in which her records are incorrectly 
found to belong to 2 different women. 
Key-based linkage method 
An enhanced version of the simple deterministic method is the key-based linkage method 
(previously known as the step-wise deterministic linkage method), which improves the 
quality of the results while still maintaining privacy. 
The AIHW developed this method and it uses both components of the SLK-581 and added 
distinguishing variables such as postcode or Indigenous status to create a series of linkage 
keys (AIHW 2011, 2012; Karmel et al. 2010). 
In these keys, components are systematically varied to account for people whose 
components vary, so for example if a person’s last name or other components have changed 
over time, their records can still be linked. This method can also account for records with 
missing components, including incomplete SLK-581s, but it does require considerably more 
resources than simple deterministic linkage. 
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This method achieves its 3 aims (using all available data, having few false links and having 
few missed links) through the use of a step-wise approach that involves linking using the 
most precise linkage key before using the next most precise linkage key, and so on. 
This method was found to be effective in discerning true links among aged care data sets 
(AIHW 2011). Nearly all (99.7%) of the links identified by this method were also identified by 
the name-based linkage strategy with clerical review (considered to be ‘true’ links), while the 
method identified 98.5% of all links made by the name-based linkage strategy.  
This method works best with a unique person identifier at a sub-national level or a 
combination of variables at a sub-national level that can be assumed to be unique (if the 
identifier was unique at the national level, there would be no need to generate further client 
identifiers). 
3.4 Options for the AODTS NMDS 
The AIHW has considered 3 methods for the AODTS NMDS:  
• simple deterministic linkage  
• key-based linkage using a unique identifier (or one assumed to be unique) at the state 
and territory level  
• key-based linkage using a unique identifier at the agency level. 
Each approach has advantages and disadvantages for the AODTS NMDS relating to 
accuracy, complexity and cost. The more accurate the client count, the more reliable the 
conclusions based on that count will be. 
Simple deterministic linkage has the advantage of requiring relatively few resources, but it 
will result in an overestimation of the number of clients where people have changed their 
names or components are recorded inconsistently. 
The client population for alcohol and other drug treatment services are typically of an age 
where people are likely to get married and possibly change their last names. However, this is 
less likely for the AODTS NMDS as the majority of treatment episodes are for males who are 
unlikely to change their name after marriage. 
Clients accessing these services may use aliases to maintain privacy or avoid criminal 
surveillance. For this reason, a deterministic method may result in an overestimation of the 
number of distinct clients, as records belonging to the same person would be identified as 
belonging to different people. In addition, any records with incomplete SLK-581s or where 
the date accuracy indicator shows that the date of birth is inaccurate cannot be linked using 
simple deterministic linkage. Analysis of pilot data supplied for the 2009 AODTS NMDS 
enhancement project found that 27% of records had incomplete SLK-581s (AIHW 2009). 
Key-based linkage using a unique identifier at the state and territory level needs more 
resources than simple deterministic linkage but is less likely to overestimate client numbers 
as it can accommodate situations in which components have changed (for example, people 
have used different names). This is particularly a major issue for longitudinal analysis over a 
number of years as the more time passes, the more likely it is that components will have 
changed. However, there is no identifier at the state or territory level that is unique to the 
client in the AODTS NMDS, and it is not reasonable to assume a combination of variables 
(such as the SLK-581) at the state and territory level would uniquely identify a client. 
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Key-based linkage using a unique identifier at the agency level would require the most 
resources for 2 reasons: the large number of treatment agencies in the AODTS NMDS 
(between 600 and 700 each year) and the lack of stability in agency numbers. This would 
mean that this method would need to be able to dynamically adjust to changes in agency 
numbers each year to avoid extensive resource-intensive manual changes to the programs 
used to generate linkage keys. This method is, however, a possibility because the AODTS 
NMDS contains a person identifier that is required to be unique at the agency level, although 
this data element is not validated.  
Finding 1 
Method selected: For analysis of 2012–13 AODTS NMDS data, the AIHW will use simple 
deterministic linkage.  
Finding 2 
Method selected: The AIHW will conduct analysis of future AODTS NMDS collections 
using a unique identifier at the agency level (resource and data quality dependent). 
Finding 3 
Data development option: The AODTS NMDS Working Group will explore the feasibility of 
introducing an identifier at the state or territory level that is unique to the client in the 
AODTS NMDS to allow for the use of key-based linkage to count distinct clients. 
 
After linkage keys have been generated using either method, it will be possible that records 
deemed to belong to the same person will have some variation in demographic information 
(for example, in 1 record the date of birth might be 1 November 1975, while in another record 
it might be 11 November 1975). As no source of information is known to be the most 
‘trustworthy’, any conflicting sets of demographic information will be resolved by randomly 
selecting one set. 
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4 Client-based analyses 
Once distinct clients can be counted, there are 2 common ways to examine the number of 
clients receiving treatment services are the number who receive treatment on an average day 
(similar to a ‘snapshot’ day), and the number who receive treatment during a year.  
The average day measure reflects the number of people in alcohol and other drug treatment 
on a typical day during the year, and gives an indication of the average number of people in 
the alcohol and other drug treatment system at any one time. It is a summary measure which 
reflects both the number of people receiving treatment, and the amount of time they spent in 
treatment. In contrast, the ‘during the year’ measure is a count of the number of unique 
individuals who received treatment at any time during the year. Each method gives the 
reader a slightly different perspective on service use. 
4.1 Client numbers  
The AODTS NMDS is based on treatment episodes that are closed in a financial year (see 
Box 1). This means that for the current year of data, client numbers and rates will refer only 
to those who have had at least one treatment episode closed in that year. 
Over time, it will be possible to estimate the total number of clients who received treatment 
in previous financial years. For example, a treatment episode that was opened on 21 October 
2010 and closed 3 May 2012 will have been submitted to the AODTS NMDS in 2011–12, as 
this is the year in which it was closed. That this episode was opened and active in 2010–11 
will only be known when data for 2011–12 are finalised (see Table 4.1 for examples). Analysis 
of available data would indicate how many years need to elapse before most or all of the 
episodes active in a particular financial year (not just those that were closed) are captured in 
the AODTS NMDS.  
Table 4.1: EXAMPLE ONLY Treatment episodes by financial years opened, 
closed and active  
Start date End date 
 
Opened Closed Active 
1/08/2010 2/02/2011 
 
2010–11 2010–11 2010–11 
21/10/2010 3/05/2012 
 
2010–11 2011–12 2010–11, 2011–12 
20/01/2011 5/12/2012 
 
2010–11 2012–13 2010–11, 2011–12, 2012–13 
During the year 
Clients receiving treatment from a publicly funded treatment agency are grouped into those 
who received treatment for their own drug use and those where the drug use was that of 
another person. 
The number of clients during the year with treatment episodes that were closed in the 
financial year is calculated by counting each distinct person only once during the financial 
year, even if they had multiple episodes that were closed in the financial year. For the 
number of clients who received treatment during the year, components may not sum to the 
total since people may receive treatment as different types of clients during the year 
(Figure 4.1).  
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Figure 4.1: EXAMPLE ONLY Overlap between clients receiving treatment for their own drug use 
and those receiving treatment for someone else’s drug use, 2012–13 
 
On an average day 
The number of clients on an average day with treatment episodes that were closed in the 
financial year is calculated by summing the number of days each client spends in closed 
treatment episodes during the financial year and dividing this total by the number of days in 
the financial year. As the AODTS NMDS only contains closed treatment episodes, this 
measure would be an underestimation of the level of activity on any given day.  
As noted above, it is possible to analyse existing data to measure how many years of data are 
needed before all the episodes active in a particular financial year (not just those that were 
closed) are captured in the AODTS NMDS. This analysis would measure the proportion of 
episodes that were active in a particular financial year that were also closed in that year. If 
the proportion were sufficiently high (for example, if 90% or more of the episodes active in 
2012‒13 were also closed in 2012‒13), then it may be worthwhile including analyses such as 
number of clients on an average day in the annual reports, as this indicates that the average 
day measure is an accurate estimation of actual treatment provided. However, if, for 
example, analysis of previous years’ data showed that on average only 50% of episodes that 
were active in a financial year were also closed in that financial year, then including data on 
the number of clients on an average day for the current collection year in annual reports 
would not give useful information as the measure would greatly underestimate the total 
volume of treatment provided. 
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Finding 4 
Planned for 2012–13 data: The AIHW will analyse the number of clients during the year 
with treatment episodes that were closed in the financial year. 
Finding 5 
Planned for 2012–13 data: The AIHW will analyse existing data (pre-2012–13) to check the 
proportion of episodes that were active in a particular financial year that are also closed in 
that year. 
Finding 6 
Planned for 2013–14 data: The AIHW will use information on the proportion of episodes 
that were active in a particular year and also closed in that year (Finding 5) to inform the 
value of including analysis of the number of clients on an average day in annual reports. 
Finding 7 
Data development option: The AODTS NMDS Working Group will explore the feasibility of 
expanding the AODTS NMDS to capture all active episodes in a financial year, not just 
episodes closed in a financial year. 
Example analysis 
In 2012–13, 101,233 people were clients of alcohol and other drug treatment services in 
Australia, and most (72%) were male (Table 4.2). Seven per cent of clients received services in 
more than one state or territory, and this proportion was similar for both males and females.  
In all states, clients were more likely to be male than female; this ranged from 79% of clients 
in State 4 to 67% in State 1.  
Table 4.2: EXAMPLE ONLY Clients receiving alcohol and other  
drug treatment services during the year by sex, states and  
territories, 2012–13  
Sex State 1 State 2 State 3 State 4 Australia 
Male 20,153 36,151 12,153 8,988 72,566 
Female 9,866 12,548 5,698 2,455 28,667 
Total 30,019 48,699 17,851 11,443 101,233 
Note: Australian total does not equal sum of states and territories as some clients receive  
services in multiple states or territories. 
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4.2 Client rates 
Exploring the relationship between the number and type of people in treatment and both the 
drug-using population and the population at large enables better understanding of how 
these populations differ and where treatment gaps may exist. Calculation of client 
population rates, both for the general population and for the drug-using population, allows 
for this comparison to be made (see Box 4.1).  
 
Box 4.1: Calculation of treatment rate 
 
𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑟𝑎𝑡𝑒 =  𝑝𝑒𝑜𝑝𝑙𝑒 𝑟𝑒𝑐𝑒𝑖𝑣𝑖𝑛𝑔 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
𝑝𝑒𝑜𝑝𝑙𝑒 𝑖𝑛 𝑡ℎ𝑒 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛   
For males aged 20–30 who use drugs: 
𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑟𝑎𝑡𝑒: 𝑚𝑎𝑙𝑒 𝑟𝑒𝑐𝑒𝑛𝑡 𝑢𝑠𝑒𝑟𝑠 𝑎𝑔𝑒𝑑 20 − 30 =  𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑎𝑙𝑒𝑠 𝑎𝑔𝑒𝑑 20 − 30𝑟𝑒𝑐𝑒𝑖𝑣𝑖𝑛𝑔 𝑑𝑟𝑢𝑔 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓𝑚𝑎𝑙𝑒 𝑟𝑒𝑐𝑒𝑛𝑡 𝑢𝑠𝑒𝑟𝑠 
𝑎𝑔𝑒𝑑 20 − 30  
 
This number is then expressed as a population rate, usually per 10,000 or 100,000.  
 
As with the number of clients, the client rates will refer only to those who have had at least 
one treatment episode that was closed in the relevant year (see Section 4.2 for more details).  
Rates can be compared by calculating the ratio of the 2 rates. Rate ratios are typically used to 
compare Indigenous and non-Indigenous rates and to give a measure of the level of 
Indigenous representation, but these can be used for other populations as well, for example, 
to compare male and female rates. These rate ratios are accompanied by crude rates to guide 
interpretation so that both the relationship between groups and the actual size of the issue 
can be explored.  
One of the challenges in measuring rate ratios for Indigenous clients is that they may receive 
treatment from agencies funded by the Office for Aboriginal and Torres Strait Islander 
Health, many of which do not supply data to the AODTS NMDS. Indigenous rates will be 
underestimated where this occurs. 
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Example analysis 
In general, rates of treatment for someone else’s drug use rose as the age group increased, 
peaking for those aged 50–59 (Figure 4.2). Someone aged 50–59 was almost 2 times as likely 
as someone aged 30–39 to receive treatment for someone else’s drug use, and almost 4 times 
as likely as someone aged 20–29. In all age groups, except those aged 10–19, females were 
more likely than males to receive treatment for someone else’s drug use.  
 
Figure 4.2: EXAMPLE ONLY Clients receiving treatment for someone else’s drug use during the 
year by sex, states and territories, 2012–13 (rate)  
Finding 8 
Planned for 2012–13 data: The AIHW will analyse the rate of clients during the year with 
treatment episodes that were closed in the financial year. 
Finding 9 
Planned for 2013–14 data: The AIHW will use information on the proportion of episodes 
that were active in a particular year and also closed in that year to inform analysis of the 















Number per 100,000 
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4.3 Time in treatment 
Better evidence about the length of time clients spend in treatment will enhance 
understanding of client retention and outcomes. Generating linkage keys will enable all 
episodes relating to a particular client to be counted and measures of time in treatment to be 
calculated. Analyses can include the average number of closed treatment episodes and the 
total time spent in treatment during the year (when all treatment episodes are combined).  
Example analysis 
Nationally, the median length of closed episodes for the client’s own drug use was almost 16 
weeks (113 days), and this ranged from just over 14 weeks (100 days) in State 2 to 18 weeks 
(126 days) in State 4. Clients had, on average, 1.6 closed episodes during 2013–14; this ranged 
from 1.1 in State 1 to 2.4 in State 2.  
Overall, there was an inverse relationship between the median length of closed episodes and 
the average number of closed episodes per client during the year. State 2 had the shortest 
median length of closed episodes and one of the highest average number of closed episodes 
per client, while states 1 and 4 had the longest median lengths of closed episodes and the 
lowest average number of closed episodes per client. 
 
Figure 4.3: EXAMPLE ONLY Closed treatment episodes for clients receiving treatment for their 
own drug use by median length and average number per client, states and territories, 2013–14 
 
Nationally, clients receiving treatment for someone else’s drug use spent, on average, 6 
weeks (44 days) in this type of treatment (Figure 4.4). This ranged from 5 weeks (35 days) in 
State 3 to 10 weeks (71 days) in State 2. In all states and territories except State 4, females 
spent longer in treatment than males—nationally, females spent 8 more days in treatment 
during the year than males. Further investigation of this finding is likely to produce better 
















State 1 State 2 State 3 State 4 Aust
States and territories 
Median length Average number
Duration in days (columns) No. closed episodes (diamonds) 
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Figure 4.4: EXAMPLE ONLY Average length of time spent in closed treatment episodes during the 
year for clients receiving treatment for someone else’s drug use, states and territories, 2013–14 
(days)  
Finding 10 
Planned for 2013–14 data: The AIHW will analyse the average number of closed episodes 
per client.  
Finding 11 
Planned for 2013–14 data: The AIHW will analyse the average length of time clients spent in 
closed treatment episodes. 
4.4 Remoteness of usual residence 
The remoteness of a location can be analysed using the ABS Australian Statistical Geography 
Standard Remoteness Structure (ABS 2011). In this classification, remoteness is based on road 
distance measurements to the nearest urban centre, where the population size of the urban 
centre is assumed to affect the availability of goods and services. Areas that share common 
characteristics of remoteness are classified into: 
• Major cities 
• Inner regional 
• Outer regional 
• Remote 
• Very remote. 
The postcode of the client’s usual residence at the start of treatment will be implemented in 
the 2013–14 AODTS NMDS collection period. This will allow the remoteness of usual 
residence to be assessed, although more robust results would be found using the Statistical 
Area 2 (SA2) of the client’s usual residence as Statistical Area boundaries are more likely 
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Example analysis 
Nationally, people from Major cities were most likely to receive alcohol and other drug 
treatment services, while those from Very remote areas were least likely (Figure 4.5). During 
2013–14, there were 108 people receiving services for every 100,000 in the population in 
Major cities, compared with 42 per 100,000 in Very remote areas.  
 
Figure 4.5: EXAMPLE ONLY Clients receiving alcohol and other drug treatment services during the 
year by remoteness of usual residence, Australia, 2013–14 (rate)  
 
Analysis of this type, along with data on drug use in the population, will give valuable 
information on geographic patterns of service use across Australia. Issues such as distance 
travelled to treatment (either because treatment is unavailable closer to the client or to 
protect privacy) could be useful in reviewing access to services. 
 
Finding 12 
Planned for 2013–14 data: The AIHW will analyse the remoteness of the client’s usual 
residence (number and rate). 
Finding 13 
Data development option: The AODTS NMDS Working Group will consider the feasibility 
of including in the AODTS NMDS the SA2 of the client’s usual residence at the start of the 
treatment episode.  
4.5 Socioeconomic status of usual residence 
The socioeconomic status of a location can be estimated using the ABS Socio-Economic 
Indexes for Areas (SEIFA). The SEIFA comprises 4 indexes that are constructed using 
information from the 5-yearly Census of Population and Housing. These 4 indexes are: 
• the Index of Relative Socio-Economic Disadvantage  








Major cities Inner regional Outer regional Remote Very remote
Remoteness area
Number per 100,000
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• the Index of Economic Resources  
• the Index of Education and Occupation.  
These indexes represent the average of all people living in the area, and not the 
socioeconomic status (SES) of a particular individual living in that area. Therefore, analyses 
using the SEIFA indicate the SES of the area of the usual residence, not the SES of the client 
or their family.  
The postcode of the client’s usual residence at the start of treatment will be implemented in 
the 2013–14 AODTS NMDS collection period. This will allow the SES of usual residence to be 
estimated, although more robust results would be found using the Statistical Area 2 (SA2) of 
the client’s usual residence.  
Example analysis 
There was no strong relationship between the SES of usual residence and receiving treatment 
for own drug use (Figure 4.6). Those from the areas of lowest SES were 1.3 times as likely to 
be receiving treatment as those from the areas of highest SES, but overall, those from areas of 
intermediate SES were most likely to be receiving treatment.  
 
Figure 4.6: EXAMPLE ONLY Clients receiving treatment for their own drug use during the year by 
socioeconomic status of usual residence, Australia, 2013–14 (rate)  
 
Finding 14 
Planned for 2013–14 data: The AIHW will analyse the socioeconomic status of the client’s 
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4.6 Patterns of drug use 
In the AODTS NMDS, the closure of a treatment episode can be triggered by a number of 
events such as a change in the main treatment type. This means that an unbroken period of 
treatment may be separated into multiple episodes (discrete periods with defined dates of 
commencement and cessation), even if the drugs of concern, such as the principal drug of 
concern, remain unchanged. With the introduction of linkage keys, it will be possible to 
count these periods of treatment by joining abutting treatment episodes.  
For example, a client has: 
• Episode 1: A principal drug of alcohol and a main treatment type of counselling from 1 
March to 15 March 
• Episode 2: A principal drug of alcohol and a main treatment type of withdrawal 
management from 16 March to 27 March 
• Episode 3: A principal drug of cannabis and a main treatment type of withdrawal 
management from 27 March to 15 April 
• Episode 4: A principal drug of alcohol and a main treatment type of counselling from 1 
June to 25 June. 
These 4 episodes can be aggregated in several ways (Figure 4.7). 
 
Figure 4.7: EXAMPLE ONLY Treatment period examples by combining abutting treatment 
episodes 
 
To date, reporting on treatment services has focused on the number of episodes by drug 
type. With the introduction of the linkage key it will be possible to count the number of 
clients and the number of treatment periods by drug type. As periods of treatment can be 
broken into multiple periods of episodes even where the principal drug of concern remains 
unchanged, the addition of periods of treatment can give more information on the profile of 
drugs of concern. This would give a more cohesive (less fractured) picture about treatment 
for a particular drug. 
Distinct client counts can also be used to explore the combinations of drugs of concern (for 
example, the client had 2 principal drugs of concern: alcohol and cannabis), while the length 
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of treatment periods can be used to explore the total time in treatment for different types of 
drugs. 
Example analysis 
In 2012–13, alcohol remained the most common principal drug of concern both when 
individual client episodes and treatment periods were considered. 
More specifically, over 90,000 closed treatment episodes had alcohol as a principal drug of 
concern, followed by cannabis (almost 65,000 episodes) (Figure 4.8).  
When episodes with the same principal drug of concern are joined to form treatment 
periods, alcohol remained the most common principal drug of concern (around 30,000 
periods, with an average of 3 episodes per period), but amphetamines were the second most 
common (almost 18,000 periods, with an average of 2 episodes per period). Although 
relatively few episodes had nicotine as the principal drug of concern, it was the most 
common principal drug of concern when distinct clients were considered. Almost 15,000 
clients had nicotine as a principal drug of concern in one or more episodes closed in 2012‒13, 
compared with almost 8,000 clients who had alcohol as a principal drug of concern in one or 
more episodes.  
 
Figure 4.8: EXAMPLE ONLY Most common principal drugs of concern by closed episodes, 
treatment periods and clients, Australia, 2012–13  
Of clients reporting heroin as their principal drug of concern, most (97%) had no or only one 
additional drug of concern (Figure 4.9). 
More specifically, of the 2,410 clients who had heroin as a principal drug of concern in  
2012–13, 33% had no other principal drugs of concern in 2012–13. A further 27% had only 
benzodiazepines as principal drug of concern in addition to heroin during 2012–13, while 
22% had only cannabis as an additional principal drug of concern. Just 3% of clients with 
heroin as a principal drug of concern also had more than 1 additional principal drug of 
concern. 











Principal drug of  
concern 
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Figure 4.9: EXAMPLE ONLY Clients with heroin as a principal drug of concern by other principal 
drugs of concern (PDOC) during the year, Australia, 2012–13  
 
Finding 15 
Future reports option: The AODTS NMDS Working Group may explore the policy 
relevance of analyses of patterns of drug use. 
4.7 Patterns of treatment  
Patterns of treatment types can be analysed in similar ways to drugs of concern (see previous 
section for details). 
Finding 16 
Future reports option: The AODTS NMDS Working Group may explore the policy 
relevance of analyses of combinations of patterns of treatment. 
  









drugs of concern 
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4.8 Pathways through treatment services 
As data for which distinct client counts can be generated accumulate over time, it will be 
possible to examine pathways through treatment. This could include: 
• analysing the drug and treatment pathways to treatment for a particular drug. For 
example, pathways to receiving treatment for heroin use could be explored by analysing 
the drugs for which a cohort of clients received treatment in the years before receiving 
treatment for heroin use. 
• analysing the pathways to treatment ‘completion’. For example, completion could be 
defined as when a client has not returned to treatment for at least 1 year (or another time 
frame). 
• analysing typical pathways that occur for clients of a particular age, or who have a 
particular drug of concern, over a specified period of time. For example, analysing the 
top 10 most common pathways (treatment types and drugs of concern) over 5 years for 
clients whose principal drug of concern in 2013‒14 was alcohol.  
• analysing the proportion of clients who return to treatment after a period of time and 
comparing them with those who do not return to treatment. 
Finding 17 
Future reports option: The AIHW may explore the analysis of pathways through treatment 
in a thematic bulletin. 
Finding 18 
Future reports option: When enough data are available, the AIHW may include the analysis 
of pathways through treatment in annual reports.  
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5 Reporting options 
5.1 Annual reports 
The AIHW currently produces annual reports based on alcohol and other drug treatment 
services reported through the AODTS NMDS. These annual reports currently cover 
information on treatment agencies, drugs of concern and types of treatment provided to 
clients. Demographic and other information about clients is also presented. As distinct client 
counts have not been available previously, this information has related to treatment 
episodes, not to distinct clients.  
With the introduction of linkage keys, and based on the findings in Chapter 4, the following 
changes will be introduced in upcoming annual reports (dependent on data quality): 
2012–13 annual report: 
• number of clients during the year with treatment episodes closed in the financial year  
• rate of clients during the year with treatment episodes closed in the financial year.  
2013–14 annual report: 
• average number of closed episodes per client 
• average length of time clients spent in closed treatment episodes 
• remoteness of client’s usual residence (number and rate) 
• socioeconomic status of client’s usual residence (number and rate). 
5.2 Thematic bulletins 
Thematic bulletins are a useful means of exploring special topics and the feasibility and 
policy relevance of analyses before inclusion in annual reports. From the findings in Chapter 
4, the following analyses are suggested for thematic bulletins in future years which could be 
prioritised by jurisdictions: 
Patterns of drug use, including: 
• combinations of drugs of concern across treatment episodes  
• total time in treatment during the year by drug of concern. 
Patterns of treatment, including: 
• types of treatment: combinations of treatment types across treatment episodes  
• total time in treatment by type of treatment. 
Pathways through treatment services, including: 
• analysing the drug and treatment pathways to treatment for a particular drug 
• analysing the pathways to treatment ‘completion’ 
• analysing typical pathways for a cohort of clients over a specified period of time (for 
example, for clients with the same drug of concern) 
• analysing the proportion of clients who return to treatment after a period of time and 
comparing the characteristics of these clients with those who do not return to treatment. 
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Glossary 
client type: clients receiving treatment from a publicly funded treatment agency are grouped 
into those who received treatment for their own drug use and those where the drug use was 
that of another person. 
combination: the result of combining the components required for a particular key. For 
example, the combination for the SLK-581 [F3G2D2M2Y4S1] for Mary Brown born 1 July 
1958 is RONAR010719582. 
component: the variables that form a particular linkage key. For example, the SLK-581 has 
the components: letters of family name, letters of given name, date of birth and sex. 
deterministic record linkage: the linkage of records is based on exact agreement or matching 
of the linkage variables such as a linkage key. Simple (one-step) deterministic record linkage 
cannot allow for variation in reporting. For example, linking 2 data sets based solely on the 
exact agreement of the SLK-581 only. However, deterministic linkage can be constructed to 
allow for variation in linkage elements (AIHW 2011). For example, distinguishing data (such 
as postcode) can be used in addition to a linkage key to improve successful matching of 
records. This method is often referred to as step-wise or key-based linkage.  
letters of family name: the combination of the second, third and fifth letters of a person’s 
family name. For example, ‘Thompson’ results in HOP; ‘Brown’ results in RON. Non-
alphabetic characters (for example, blank spaces or hyphens) are ignored when counting the 
position of each character. Where a family name contains fewer than 5 letters, a ‘2’ is 
substituted for the missing letters. 
letters of given name: the combination of the second and third letters of a person’s given 
name. For example, ‘Elizabeth’ results in LI; ‘Robert’ results in OB. Non-alphabetic characters 
(for example, blank spaces or hyphens) are ignored when counting the position of each 
character. Where a given name contains fewer than 3 letters, a ‘2’ is substituted for the 
missing letters. 
main treatment type: the main activity determined at assessment by the treatment provider 
to treat the client's alcohol and/or drug problem for the principal drug of concern. 
principal drug of concern: the main drug, as stated by the client, that has led a person to 
seek treatment from the service. 
statistical linkage key (or linkage key): a variable that consists of the concatenation of 
specified components. For example, a linkage key formed from the concatenation of the date 
of birth component and the sex component would be the linkage key [D2M2Y4S1].  
treatment episode: a defined period of contact, with defined dates of commencement and 
cessation, between a client and a treatment provider or team of providers in which there is 
no change in the main treatment type or the principal drug of concern, and there has not 
been a non-planned absence of contact for greater than 3 months. A treatment episode is 
considered closed where: 
• the treatment is completed or has ceased 
• there has been no contact between the client and treatment provider for 3 months 
• there is a change in the main treatment type, principal drug of concern or delivery 
setting. 
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Developing client-based analyses 
for reporting on alcohol and 
other drug treatment services
Developing client based analysis for reporting on alcohol and 
other drug treatment services outlines AIHW intended analysis 
techniques to:
-  estimate the number and rate of clients receiving alcohol and 
other drug treatment 
-  explore patterns of drug use and pathways through treatment 
-  explore the characteristics of different client groups, for 
example, those who return to treatment over many years with 
multiple drugs of concern or treatment types.
Some analyses described either require, or would be improved 
by, future data development activities for this collection. Public 
consultation is open until 28 February 2014.
